The Ivy

Charlie Munger became famous in the investment world as Warren Buffett’s right-hand man at Berkshire Hathaway and the architect of Berkshire’s philosophy of buying great businesses at fair prices versus the prior mantra of buying good businesses at great prices.

Over a nearly 100-year life, Munger would pass up innumerable investment opportunities, choosing to put money only into the few that truly offered exceptional value.

 » Read more about: Why Charlie Munger Never Sold Costco Stock — Even When It Looked Overvalued  »

News just came out that Warren Buffett was back in the market buying again and this time the stock comes as a bit of a surprise, it’s Pool Corp.

On the back of the news, Pool share price popped 3% as a stampede of buyers flooded in after the Oracle of Omaha. So what is it about this swimming pool supplies company that has piqued the interest of the 93 year old billionaire?

 » Read more about: Buffett Dives Into Pool: Uncovering the Oracle’s Latest Surprise Bet  »

Few investors realize that APA Corporation, formerly Apache Corporation, has quietly become a key player in one of the most sought-after regions for oil and gas exploration: Suriname.

This emerging hotspot may very well reset APA’s growth trajectory but it appears few investors have cottoned on to its promise.

APA Corporation’s joint venture with TotalEnergies in Suriname’s Block 58 is one of the most under-the-radar exploration stories in the energy sector today yet early drilling results have confirmed multiple discoveries,

 » Read more about: 51.6% Upside In This Under-the-Radar Energy Play  »

At 94 years old, Warren Buffett remains perhaps the most-watched investor in the world. Every decision the value investing legend makes is carefully studied, often to determine his thoughts about the broader market and stock valuations.

This year has seen Buffett appear to turn more bearish than in any past period, with Berkshire Hathaway selling a net amount of $127 billion of stock in just the first three quarters.

 » Read more about: Does Buffett Think Markets Will Tumble Soon?  »

Chevron (NYSE:CVX) ranks among Warren Buffett’s favorite stocks and is Berkshire Hathaway’s fifth-largest position with total exposure of $18.6 billion.

While Buffett has recently slashed some of Berkshire’s holdings, including his stake in Apple, he has only trimmed Chevron by single-digit percentages this year.

Is this Buffett favorite a buy,

 » Read more about: Will This Buffett Favorite Skyrocket Under Trump?  »

Costco (NASDAQ:COST) has seen enormous success with its membership-driven wholesale approach to retail shopping.

Listed as the third-largest retailer in the world behind only Walmart and Amazon, Costco is an increasingly popular option among cost-conscious shoppers looking to stretch their household budgets by buying in bulk at low prices.

Famously,

 » Read more about: 1 Trillion Reasons to Buy Costco?  »

Nvidia (NASDAQ: NVDA) has rapidly cemented its place as one of the most sought-after stocks after seizing the role of toll road through which all big tech must travel to enter the artificial intelligence ecosystem.

Recently, Nvidia drew interest from billionaire investor Paul Tudor Jones, who raised his position by a staggering 853% to 273,294 shares,

 » Read more about: AI Powerhouse Sees 853% Increase From Connecticut Billionaire  »

Berkshire Hathaway (NYSE:BRK.B) is arguably one of the most successful companies in American history. The conglomerate founded by Warren Buffett now owns stakes in both large public companies and several wholly-owned subsidiaries.

Berkshire itself has also been a remarkable investment vehicle for its shareholders, boasting a 30-year total return of over 3,000%.

 » Read more about: The Magnificent 7 Have a New Trillion Dollar Rival  »

Recently, an under-the-radar tech company has captured the interest of top-tier investment funds. Hedge funds have quietly been acquiring significant shares that displays a conviction in this company’s potential to redefine its market.

So, what’s the stock is it a buy on the dip?

Key Points

• Shopify’s shift beyond subscriptions to financial services,

 » Read more about: Is Shopify a Slam Dunk Buy on the Dip?  »

Merck & Co. (NYSE: MRK) might be best known for its drugs like Keytruda and Gardasil, but those blockbusters haven’t been enough to get shareholders excited as the share price has fallen under water this year, down 6%.

It may well be a pharmaceutical powerhouse but recent price weakness suggests that Merck may be flying under the radar for investors,

 » Read more about: 1 Titan Health Stock Is Way Too Cheap  »